We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VZN:SIXVZ Holding AG Analysis

Data as of 2026-03-14 - not real-time

CHF 148.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

VZ Holding AG trades at CHF 148, well below its DCF fair value of CHF 453, indicating a substantial valuation gap. The stock’s trailing PE of 24.9 is markedly higher than the asset‑management industry average of 16.4, reflecting a premium that may be justified by its strong operating margin of 45.9% and profit margin of 37.6%. Technical signals are mixed: the price sits just above the 20‑day SMA (CHF 146.4) but below the 50‑day SMA (CHF 151.4), while the MACD histogram is positive, suggesting short‑term bullish momentum. Volatility remains elevated at 26.6% over the past 30 days, yet beta is modest at 0.48, pointing to limited systematic risk. The company generates robust free cash flow (CHF 896 M) and sustains a dividend yield of 1.99% with a payout ratio under 50%, supporting dividend sustainability. Overall, the combination of undervalued DCF, solid cash generation, and manageable risk makes the stock attractive for medium‑ to long‑term investors.
Actionably, investors should consider buying on dips toward the support level of CHF 139, targeting the resistance at CHF 153, while monitoring the MACD and RSI for confirmation of sustained momentum.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Positive MACD histogram indicating near‑term bullish pressure
  • Price positioned between support (CHF 139) and resistance (CHF 153)
  • Neutral RSI around 50 suggesting no immediate overbought/oversold condition

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value far exceeds current market price
  • Strong operating and profit margins with consistent cash flow
  • Sustainable dividend yield with a comfortable payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Low beta and modest systematic risk
  • Stable business model across Switzerland, Germany, and England
  • Long‑term undervaluation coupled with reliable dividend policy

Key Metrics & Analysis

Financial Health

Revenue Growth7.10%
Profit Margin37.62%
P/E Ratio24.9
ROE21.07%
ROA2.25%
Debt/Equity60.89
P/B Ratio5.0
Op. Cash FlowCHF215.0M
Free Cash FlowCHF896.3M
Industry P/E16.4

Technical Analysis

TrendBearish
RSI50.0
SupportCHF 139.20
ResistanceCHF 153.00
MA 20CHF 146.36
MA 50CHF 151.35
MA 200CHF 160.57
MACDBullish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair ValueCHF 453.57
GradeUndervalued
TypeGrowth
Dividend Yield1.99%

Risk Assessment

Beta0.49
Volatility26.65%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.